TFS continues to recognize the importance of partnerships in the clinical development and brings together biotech industry expert, investors and clinical research professionals to discuss the changing landscape of biopharma….
TFS, a leading mid-size CRO providing clinical development solutions to biopharmaceutical companies, joins Medidata Partner Program and combines its therapeutic expertise with leading-edge technologies. TFS has been accredited to the…
Dr. Bassem Saleh new Chief Executive Officer of TFS The Board of Directors of TFS, a leading mid-size CRO providing clinical development solutions to biopharmaceutical companies, appointed Dr. Bassem Saleh…
On September 19th, TFS hosted a seminar in Medicon Village starting a much needed discussion about the changes impacting the biopharmaceutical industry. Representatives from the biotech, academic and investor community…
On January 14, 2019, it was announced that Ratos acquires remaining shares in TFS. This acquisition is a natural next step of the change in ownership structure that started two…
